LabPulse.com

Lab News

Viome's screening tool given 'breakthrough device' designation
May 7, 2021 -- Viome announced on May 6 its proprietary messenger RNA analysis technology combined with its artificial intelligence platform has been designated a breakthrough device by the U.S. Food and Drug Administration for early detection of oral cancer and throat cancer. Read More

3 in Fla. charged in $47M genetic testing scheme
May 5, 2021 -- Three men in Florida were charged for $47 million in fraud for allegedly referring medically unnecessary genetic testing to labs in exchange for kickbacks, according to an indictment unsealed on April 5. Read More

Qiagen posts strong sales, earnings growth in Q1
May 4, 2021 -- Strong growth in both COVID-19 and non-COVID-19 product groups propelled Qiagen to a 48% increase in net sales at constant exchange rates in its first quarter. Read More

Labcorp to buy intellectual property from Myriad Genetics
May 3, 2021 -- Labcorp plans to buy some of Myriad Genetics' operating assets and intellectual property from its autoimmune business unit, including its Vectra rheumatoid arthritis assay. Read More

Thermo Fisher announces Q1 revenue increase
April 29, 2021 -- Thermo Fisher Scientific said that its efforts to help scale vaccine production and support diagnostic testing globally during the COVID-19 pandemic were partially responsible for significant revenue growth in its first quarter of 2021. Read More

Hologic's growth continues in Q2
April 29, 2021 -- Hologic has continued to post significant increases in revenue, with revenues doubling in the company's second quarter. The growth was driven primarily by demand for the company's SARS-CoV-2 assays, but revenues in Hologic's Breast Health business also increased. Read More

Illumina donates $60M in NGS tools to build genomic network
April 28, 2021 -- Illumina is donating $60 million in next-generation sequencing (NGS) platforms, reagents, and support to create a comprehensive pathogen genomic network in South Asia. Read More

Venture capital funding for digital pathology tops $860M
April 27, 2021 -- While 2014-2017 reflected a relatively quiet period for investment in digital pathology, over the last three years there has been a significant uptick in funding, with a focus on artificial intelligence. Imogen Fitt of U.K. market insights firm Signify Research offers a perspective. Read More

SpeeDx secures European CE-IVD Mark for COVID-19 test
April 27, 2021 -- SpeeDx has received the European CE-IVD Mark for its PlexPCR test for SARS-CoV-2. The test targets two regions of the SARS-CoV-2 genome. Read More

FDA grants EUA for PathogenDx COVID-19 test
April 27, 2021 -- The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) to PathogenDx for the company's microarray-based COVID-19 test, DetectX-Rv. Read More

1 2 3…172 next »

Webinars/Videos